Search

Your search keyword '"Deluche, Elise"' showing total 238 results

Search Constraints

Start Over You searched for: Author "Deluche, Elise" Remove constraint Author: "Deluche, Elise"
238 results on '"Deluche, Elise"'

Search Results

1. Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial

2. Management of patients with advanced epithelial ovarian cancer: a European survey

6. Prognosis and chemosensitivity of non-colorectal alimentary tract cancers with microsatellite instability

7. Application en France des recommandations européennes 2021 sur le cancer de l’endomètre

13. Multicenter evaluation of breast cancer patients’ satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic

16. Impact of body mass index on overall survival in patients with metastatic breast cancer

17. Surgical Site Infections after glioblastoma surgery: results of a multicentric retrospective study

18. Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016

20. Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort

21. Variability of treatment of locally advanced cervical cancer: How French multidisciplinary teams follow European guidelines?

22. THERANOVA-LIM: Optimizing the city hospital link to support patients on oral anticancer drugs

26. Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study

31. Prospective evaluation of an anti-cancer drugs management programme in a dedicated oral therapy center (DICTO programme)

35. Clinical management of molecular alterations identified by high throughput sequencing in patients with advanced solid tumors in treatment failure: Real-world data from a French hospital

39. Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study

40. 2022-RA-787-ESGO ESGO guidelines on the management of endometrial cancer. Weaknesses and controversies in france and french-speaking switzerland. Results of a delphi survey

41. Mechanism of action and resistance to Trastuzumab Deruxtecan in patients with metastatic breast cancer: the DAISY trial

44. TEDOVA/GINECO-OV244b/ENGOT-ov58 trial: Neo-epitope based vaccine OSE2101 alone or in combination with pembrolizumab versus best supportive care (BSC) as maintenance in platinum-sensitive recurrent ovarian cancer with disease control after platinum.

45. Renin-Angiotensin-System Inhibitors for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: OncoToxSRA, a Preliminary Cohort Study

47. Abstract PD8-02: Trastuzumab deruxtecan (T-DXd) for advanced breast cancer patients (ABC), regardless HER2 status: A phase II study with biomarkers analysis (DAISY)

48. Primary Renal Tumour Response in Patients Treated with Nivolumab for Metastatic Renal Cell Carcinoma: Results from the GETUG-AFU 26 NIVOREN Trial

Catalog

Books, media, physical & digital resources